News
Analytical Lab Instruments Manufacturing Sees Steady Growth
As per the latest BCC Research study, demand for Analytical Laboratory Instruments Manufacturing: Global Markets is all set to increase from $60.9 billion in 2023 to touch $82.5 billion by 2028, at a CAGR of 6.3% from 2023 through...
News
Overdose Prevention and Response in West Virginia: Progress and Challenges
West Virginia has been at the forefront of battling a significant public health crisis: the alarming rates of drug overdoses. Find out aboutthe challenges of addiction and the difficulties of overdose prevention and response in West Virginia. We willexplore...
News
Schreiner MediPharm Debuts Sustainable Closure Seals at Pharmapack Paris
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, debuted
sustainable closure seals for pharmaceutical packaging at Pharmapack Paris in January. The ecofriendly closure seals combine high levels of functionality and tamper protection while...
News
Chanelle Pharma, Ireland’s largest indigenous manufacturer of generic pharmaceuticals, acquired by Exponent
Headquartered in Loughrea, Co. Galway, Chanelle Pharma is Ireland’s largest indigenous manufacturer of generic pharmaceuticals for animal and human health. The terms of the sale have not been disclosed.
Founded in 1985 by Michael H Burke, today Chanelle Pharma employs...
IT & Data Management
SDG 2030 Agenda Pushed By Lab Automation & Digital Shift
The UN 2030 Agenda of the Sustainable Development Goals goes on to cover the economic, social, as well as environmental dimensions when it comes to development. In this regard, healthcare as well as diagnostic sectors go on to translate...
Drug Research
Data-Driven Discoveries Get Powered By Lab Connectivity
Technology has gone on to change almost every aspect when it comes to the daily lives and has swiftly redefined the way one manages science. The digital disruption, which has been brought about by a massive influx of innovative...
IT & Data Management
Big Pharma Eye Investing 7% Revenue On Next-Gen Labs By 2025
Pharmaceutical organizations happen to be rethinking their approach when it comes to the setup and operations of their labs, with an emphasis on speeding up digitalization, making the utmost use of AI, enhancing processes, and also building the right...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.